Future costs in cost-effectiveness analyses: past, present, future

23 January 2019 - There has been considerable debate on the extent to which future costs should be included in cost-effectiveness ...

Read more →

Bitter pill over PBS savings shortfall

6 November 2018 - A key savings measure for the Pharmaceutical Benefits Scheme came up $864 million short last year, ...

Read more →

Cost of clinical trials for new drug FDA approval are fraction of total tab

24 September 2018 - Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, ...

Read more →

Drug shortages may add $230 million to annual U.S. drug costs

22 September 2018 - Prescription drug shortages may drive up prices twice as much as they would rise with medicines ...

Read more →

Medicare-funded cancer genetic tests: a note of caution

3 September 2018 - Clinicians need appropriate education and support in keeping pace with the genomics revolution. ...

Read more →

CMS releases formal approach to ensure Medicaid demonstrations remain budget neutral

22 August 2018 - Agency reinforces commitment to transparency and controlling costs; provides new tool. ...

Read more →

Sydney Uni software helps hospitals cut medicine bill

25 July 2018 - A software platform developed at the University of Sydney could save Australia’s hospitals more than $100 ...

Read more →

Total costs of chimeric antigen receptor T-cell immunotherapy

26 April 2018 - In 2017, the US FDA approved the drugs tisagenlecleucel (Kymriah; Novartis) and axicabtagene ciloleucel (Yescarta; Kite Pharma) ...

Read more →

The cost of cancer to Australia's economy

7 April 2018 - When breast cancer survivor Margie Foumakis was told she couldn’t come back to work part-time after ...

Read more →

Better health care helps fiscal health

24 October 2017 - The Treasurer’s recognition of the importance to the economy of integrated, patient-centred health care injects fresh ...

Read more →

Rising cancer drug costs in the USA

20 October 2017 - The price of patented cancer drugs in the USA rises steadily after their launch, according to a ...

Read more →

The cost of developing drugs is insane. That paper that says otherwise is insanely bad.

16 October 2017 - You probably know this poem, or at least the story it tells. One man likens the ...

Read more →

Trajectories of injectable cancer drug costs after launch in the United States

11 October 2017 - Cancer drug prices at launch have increased in recent years. It is unclear how individual drug prices ...

Read more →

A flawed study depicts drug companies as profiteers

9 October 2017 - Even the authors admit their selection criteria are a ‘critical limitation.’ That’s an understatement. ...

Read more →

Final budget outcomes reveal industry efforts to take pressure off PBS

26 September 2017 - The Final Budget Outcome papers released today reveal the enormous efforts of the members of Medicines ...

Read more →